NexImmune, Inc. (NASDAQ:NEXI – Get Free Report) shares dropped 8.5% on Thursday . The company traded as low as $0.23 and last traded at $0.23. Approximately 944 shares were traded during trading, a decline of 100% from the average daily volume of 762,352 shares. The stock had previously closed at $0.25.
NexImmune Stock Down 8.5 %
The business’s 50 day simple moving average is $0.27 and its 200 day simple moving average is $1.14. The stock has a market cap of $321,129.00, a price-to-earnings ratio of -0.01 and a beta of 1.68.
About NexImmune
NexImmune, Inc, a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform.
Read More
- Five stocks we like better than NexImmune
- What Are Dividend Champions? How to Invest in the Champions
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- 3 Fintech Stocks With Good 2021 Prospects
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Business Services Stocks Investing
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for NexImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexImmune and related companies with MarketBeat.com's FREE daily email newsletter.
